Anti-cancer agent
AssigneeNippon Chemical Industrial Co., Ltd.
InventorsNobuhiko Oohara, Kazuhiro Nakatsui
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Chemical Industrial Co., Ltd.
InventorsNobuhiko Oohara, Kazuhiro Nakatsui
Estimating the term…
The anti-cancer agent of the present invention contains at least one kind of phosphine transition metal complex selected from a group of compounds represented by the following Formulae (1a) to (1d). According to this anti-cancer agent, an anti-cancer agent is provided which has a higher anti-cancer activity and lower toxicity compared to anti-cancer agents in the related art. In Formulae (1a), (1b), (1c), and (1d), R1 and R2 represent a linear or branched alkyl group, and R4 has a higher priority than R2 as ranked according to RS notation. R3 and R4 represent a hydrogen atom or a linear or branched alkyl group. M represents an atom of a transition metal selected from a group consisting of gold, copper, and silver. X− represents an anion.
An anti-cancer agent comprising:
Dependencies are inferred from the claim text.